{"id":"W3129801150","doi":"10.1016/j.jval.2017.08.764","title":"Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Golimumab; Adalimumab; Secukinumab; BASDAI; Certolizumab pegol; BASFI; Infliximab; Population; Ankylosing spondylitis; Etanercept; Cost effectiveness; Adverse effect; Internal medicine; Disease; Tumor necrosis factor alpha; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005919046,0.00151837,0.002559024,0.004210047,0.00134456,0.004486363,0.001995995,0.002044485,0.006515542],"category_scores_gemma":[0.0213167,0.000613269,0.004595648,0.007622859,0.001150042,0.001142617,0.001033145,0.003429847,0.000205355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1135057,"about_ca_system_score_gemma":0.1148759,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9557791,"about_ca_topic_score_gemma":0.9594419,"domain_scores_codex":[0.9921854,0.00303379,0.0004398756,0.0003261712,0.002820662,0.001194141],"domain_scores_gemma":[0.9913834,0.003054916,0.0006447927,0.0001127031,0.003826748,0.000977417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03435083,0.00123612,0.08640594,0.02736735,0.03995691,0.001667212,0.001421643,0.1632263,0.00294189,0.1304774,0.1239856,0.3869628],"study_design_scores_gemma":[0.01947877,0.005947979,0.4106461,0.03595177,0.08681656,0.00247525,0.005872041,0.1278754,0.002302299,0.05043753,0.250577,0.001619284],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2433607,0.4790832,0.005025313,0.1403352,0.002242218,0.001086943,0.03548983,0.000123265,0.09325327],"genre_scores_gemma":[0.8817942,0.09757809,0.0045814,0.006046704,0.0007022719,0.000212116,0.005098687,0.00004919211,0.003937318],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1135057,"threshold_uncertainty_score":0.8235455,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08393438153360656,"score_gpt":0.3907806412306049,"score_spread":0.3068462596969984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}